Showing results (691-700 of 785) with videos related to
Sort By:
Pageof 79
The New England Journal of Medicine|September 25, 2024
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative ColitisBruce E Sands, Brian G Feagan, Laurent Peyrin-Biroulet, et al.Inflammatory Bowel Diseases|August 15, 2020
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International SurveyCharles N Bernstein, Siew C Ng, Rupa Banerjee, et al.Nature Communications|January 21, 2025
Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patientsYu Zhao, Ran Zhou, Bingqing Xie, et al.Lancet (London, England)|December 20, 2024
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studiesDavid T Rubin, Jessica R Allegretti, Julián Panés, et al.Gastroenterology|September 2, 2023
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction StudyLaurent Peyrin-Biroulet, Jessica R Allegretti, David T Rubin, et al.Inflammatory Bowel Diseases|October 24, 2019
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's DiseaseJames D Lewis, Paul Rutgeerts, Brian G Feagan, et al.Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Ulcerative ColitisEdward V Loftus, Jean-Frédéric Colombel, Brian G Feagan, et al.Inflammatory Bowel Diseases|May 1, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trialAnita Afzali, Silvio Danese, Remo Panaccione, et al.Journal of Crohn'S & Colitis|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensusPauline Wils, Vipul Jairath, Bruce E Sands, et al.Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patientsYu Zhao, Ran Zhou, Bingqing Xie, et al.Pageof 79